Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin?

James D Douketis1, Magda Melo, Chaim M Bell

  • 1Department of Medicine, McMaster University and St. Joseph's Healthcare, Hamilton, Ontario, Canada. jdouket@mcmaster.ca

The American Journal of Medicine
|April 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between sedative prescriptions after hospital discharge and falls and other adverse events in older adults: a population-based cohort study.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same author

Anesthesia for cataract surgery in Canada: deploying a limited workforce where it matters most.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same author

Warfarin Prescribing Practices Nearing End of Life.

Thrombosis and haemostasis·2026
Same author

Pharmacist-Led Hospital Discharge Care-Identifying Those Who Benefit Most.

JAMA network open·2026
Same author

Direct Oral Anticoagulant Level Testing Before Surgery-Measure for Measure.

JAMA network open·2026
Same author

"Perioperative management of direct oral anticoagulants in patients having a high-bleed-risk surgery or neuraxial procedure: the Perioperative Anticoagulant Use for Surgery Evaluation 2 pilot randomized trial": reply.

Journal of thrombosis and haemostasis : JTH·2025
Same journal

GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

The American journal of medicine·2026
Same journal

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026
Same journal

Cave Canem - Beware of the Dog.

The American journal of medicine·2026
Same journal

Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

The American journal of medicine·2026
Same journal

Mesenteric Panniculitis.

The American journal of medicine·2026
Same journal

Hypercalcemia and hyperferritinemia in a patient with Graves' disease disease.

The American journal of medicine·2026
See all related articles

Long-term use of statins may reduce bleeding risk in atrial fibrillation patients on warfarin. Recent statin use showed no association, suggesting further research is needed to confirm this protective effect.

Area of Science:

  • Cardiology
  • Pharmacology
  • Epidemiology

Background:

  • Atrial fibrillation (AF) patients on warfarin have an increased bleeding risk.
  • Concomitant use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) has been observed to potentially lower this bleeding risk.

Purpose of the Study:

  • To investigate the association between statin use and the risk of bleeding in patients with atrial fibrillation who are prescribed warfarin.
  • To determine if statin therapy modifies bleeding risk in this specific patient population.

Main Methods:

  • A population-based, nested case-control study was conducted using linked administrative databases in Ontario, Canada.
  • Eligible patients (≥66 years, AF, warfarin users) were followed for upper gastrointestinal or intracranial bleeding.

Related Experiment Videos

  • Logistic regression analysis was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for bleeding risk associated with statin use.

    • Main Results:

    • Long-term statin use (≥1 year) was associated with a statistically significant decreased risk of bleeding (OR=0.80; 95% CI, 0.66-0.97).
    • No significant association was found between recent statin use (<6 months) or statin use of any duration and bleeding risk.
    • Potential confounding by a health-user effect was suggested for the observed associations.

    Conclusions:

    • Long-term statin use may be linked to a reduced risk of bleeding in warfarin-treated atrial fibrillation patients.
    • Further research is warranted to confirm this potential association and elucidate underlying mechanisms.